Istvan Edes
Istvan Edes
Professor of Cardiology, Institute of Cardiology, University of Debrecen, Hungary
Email verificata su med.unideb.hu
Titolo
Citata da
Citata da
Anno
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
38472013
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and …
WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ...
European heart journal 28 (20), 2539-2550, 2007
32332007
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre …
European Trial on Reduction of Cardiac Events with Perindopril in Stable ...
The Lancet 362 (9386), 782-788, 2003
26792003
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
10182008
Cardiomyocyte stiffness in diastolic heart failure
A Borbély, J Van Der Velden, Z Papp, JGF Bronzwaer, I Edes, ...
circulation 111 (6), 774-781, 2005
5222005
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth, J Boczán, N Kedei, E Lizanecz, Z Bagi, Z Papp, I Édes, L Csiba, ...
Molecular Brain Research 135 (1-2), 162-168, 2005
4352005
EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events …
KM Fox
Lancet 362, 782-788, 2003
348*2003
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium
A Borbély, I Falcao-Pires, L Van Heerebeek, N Hamdani, I Edes, ...
Circulation research 104 (6), 780-786, 2009
3162009
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
E Kiss, G Jakab, EG Kranias, I Edes
Circulation research 75 (2), 245-251, 1994
3061994
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
2872018
Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca2+ Sensitivity of Cardiac Myofibrils and …
I Edes, E Kiss, Y Kitada, FM Powers, JG Papp, EG Kranias, RJ Solaro
Circulation research 77 (1), 107-113, 1995
2661995
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ...
International journal of cardiology 159 (2), 82-87, 2012
2622012
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
M Gyöngyösi, W Wojakowski, P Lemarchand, K Lunde, M Tendera, ...
Circulation research 116 (8), 1346-1360, 2015
2532015
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Z Papp, K Csapó, P Pollesello, H Haikala, I Édes
Cardiovascular drug reviews 23 (1), 71-98, 2005
1592005
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
M Gyöngyösi, I Lang, M Dettke, G Beran, S Graf, H Sochor, N Nyolczas, ...
Nature Clinical Practice Cardiovascular Medicine 6 (1), 70-81, 2009
1552009
The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial
P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ...
Lancet 353 (9146), 9-13, 1999
1391999
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ...
European heart journal 38 (9), 648-660, 2017
1332017
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig
S Szilágyi, P Pollesello, J Levijoki, P Kaheinen, H Haikala, I Édes, Z Papp
European journal of pharmacology 486 (1), 67-74, 2004
1332004
Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus
T Szerafin, N Erdei, T Fülöp, ET Pasztor, I Édes, A Koller, Z Bagi
Circulation research 99 (5), e12-317, 2006
1262006
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo …
HA Ghofrani, G Simonneau, AM D'Armini, P Fedullo, LS Howard, X Jaďs, ...
The Lancet Respiratory Medicine 5 (10), 785-794, 2017
1182017
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20